• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Moderna, Immatics agree to a cancer-focused collab that could top $1.7B

cafead

Administrator
Staff member
  • cafead   Sep 11, 2023 at 11:52: AM
via Moderna and Immatics, a clinical-stage biopharmaceutical company based in Germany, announced a multi-platform strategic collaboration that could exceed $1.7 billion Monday morning.

article source
 

<